Richard Hakes, a H&N cancer patient and Press Citizen freelance columnist featured the thermoplastic masks made for pediatric patients undergoing treatment in our clinic. During the course of his six-week treatment he recounted the love/hate relationship with his mask and featured the team of...
News
The significance of a research abstract published at the American Academy of Physicists in Medicine (AAPM) annual meeting was highlighted by Elekta, our MR-Linac vendor. In the abstract " Surrogate Gating Strategies for the Elekta Unity MR-Linac Gating System", the authors established proxy...
The Unity MR-Linac makes adaptive planning possible, which is especially effective for stereotactic body radiation therapy (SBRT) treatments in the liver due and lung to the excellent contrast of the MRI. Performing a patient specific quality assurance (PSQA) measurement on every liver SBRT...
FRRBP faculty members convened this Saturday during a morning of thoughtful introspection to analyze the successes and challenges facing the program. Great ideas and thoughtful planning were evident at the FRRBP retreat held in the PBDB.
Carryn Anderson MD, is one of 48 Radiation Oncologists selected this year as an ASTRO Fellow. The fellowship program recognizes members of the society for their outstanding contributions in at least two of these four areas: Research, Patient Care, Education and Leadership/Service. Dr. Anderson will...
Jessica Williams was presented with the Professional Recognition Program Award
James Byrne, MD, PhD is the 2024 Early Career Scholar of the Year.
An innovative upgrade to @IowaRadOnc’s MRI-Linac is featured as an Editor’s Choice article in Physics World . Following the introduction of Comprehensive Motion Management (CMM) to the Elekta Unity MR Linac, the team noted the ability of the system to perfectly track target motion even during...
A drinkable carbon monoxide (CO) foam is the latest development in a series of gas-entrapped materials (GEMs) that deliver therapeutic doses to cancer cells.
Congrats to the Michelle Howard and her team of researchers on the successful renewal of funding from the The Pediatric Brain Tumor Research Fund